Associated Capital Reports Results for the Third Quarter 2024
November 08, 2024 16:30 ET
|
Associated Capital Group, Inc.
AUM: $1.34 billion at September 30, 2024 Book Value per share ended the quarter at $42.02 Returned $45.9 million to shareholders through dividends declared and share repurchases in the third quarter...
Greenridge Exploration Grants Incentive Stock Options
November 08, 2024 16:30 ET
|
Greenridge Exploration Inc.
VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | OTC: GXPLF | FRA: HW3), has granted an aggregate of 300,000...
Teva to Present at the Jefferies London Healthcare Conference
November 08, 2024 16:30 ET
|
Teva Pharmaceutical Industries Ltd
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the...
Arhaus Opens Showroom in Corte Madera, California
November 08, 2024 16:30 ET
|
Arhaus, Inc.
ARHAUS OPENS SHOWROOM IN CORTE MADERA, CALIFORNIA
Ascot Reports Third Quarter 2024 Results
November 08, 2024 16:30 ET
|
Ascot Resources Ltd.
VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is pleased to announce the Company’s unaudited financial...
Radius Recycling, Inc. Appoints Marc Hathhorn as Chief Operating Officer
November 08, 2024 16:30 ET
|
Radius Recycling
PORTLAND, Ore., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today announced the appointment of Marc Hathhorn as Executive Vice President and Chief Operating Officer,...
Planet 13 Announces Q3 2024 Financial Results
November 08, 2024 16:29 ET
|
Planet 13 Holdings Inc.
Q3 2024 Revenue of $32.2 million Q3 2024 Net loss of $7.4 million Q3 2024 Adjusted EBITDA of $1.3 million All figures are reported in United States dollars ($) unless otherwise indicated LAS...
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
November 08, 2024 16:23 ET
|
Autolus Therapeutics plc
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia
CNL Strategic Capital Announces Operating Results for Third Quarter 2024
November 08, 2024 16:22 ET
|
CNL Strategic Capital
Orlando, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- CNL Strategic Capital, LLC (CNL Strategic Capital or the Company) seeks to provide current income and long-term appreciation to investors by...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 08, 2024 16:22 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 November 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
- November 08, 2024 16:30 ET Associated Capital Reports Results for the Third Quarter 2024
- November 08, 2024 16:30 ET Arhaus Opens Showroom in Corte Madera, California